Resat Cinar, BPharm, PhD, MBA

February 13th at 1:00PM MST

Cannabinoid Receptor 1 in Lungs: Driving under the influence of endocannabinoids and cannabinoids towards inflammatory lung diseases

Dr Resat Cinar is a principal investigator and the chief of Section on Fibrotic Disorders at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH) since January 2021 His research identified two lead compounds with therapeutic efficacy and druggable features in preclinical studies of fibrosis and metabolic disorders These compounds are licensed by Inversago Pharma, since acquired by Novo Nordisk. Dr Cinar’s current research at NIH focuses on understanding the cellular and molecular mechanisms of cannabinoid 1 receptor signaling in inflammatory and fibrotic lung diseases.

Register Here

Previous Webinars

Godfrey Pearlson, PHD.

10 October 2024, 1:00PM MST

Cannabis and driving: knowns and known unknowns

Dr. Pearlson’s medical training was at the University of Newcastle upon Tyne in England. Following internship he completed a graduate degree in philosophy at Columbia University in New York and was then successively a resident, postdoctoral fellow and faculty member at Johns Hopkins […]

Read More »

Suman Chandra, MPhil, PhD.

18 September 2024, 11:AM MST

Cannabis: An Old Plant with New Horizons, Botany and Biomass Production for the Drug Development

Dr. Chandra earned his M.Phil. degree in Environmental Plant Physiology and his Ph.D. in Plant Physiology from The High Altitude Plant Physiology Research Center, HNB Garhwal University (A Central University), India. From 1992 to 2000, […]

Read More »

Carrie Cuttler, PHD.

12 September 2024, 1:00PM MST

Chronic and Acute Effects of High Potency Cannabis Flower and Concentrates on Cognition

Dr. Carrie Cuttler received her Ph.D. in Psychology at the University of British Columbia (UBC) and subsequently conducted a post-doctoral fellowship in the Department of Psychiatry at UBC. She is currently an Associate Professor and Director of […]

Read More »

Dmitry Kurouski, PhD

Raman spectroscopy-assisted diagnosis of cannabis physiological differences

Dmitry Kurouski earned his MS in Biochemistry from Belarusian State University, Belarus and PhD (Distinguished Dissertation) in Analytical Chemistry from SUNY Albany, NY, USA. After a Postdoc in the laboratory of Professor Richard P. Van Duyne at Northwestern University, Dr Kurouski joined BoehringerIngelheim Pharmaceuticals, where he worked […]

Read More »

Elise Weerts, Ph.D.

Interactions of Delta-9 Tetrahydrocannabinol

July 11, 2024, 1:00 PM

Dr. Weerts is a Professor in the Department of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine, and core faculty in the preclinical Division of Behavioral Biology (DBB) the Behavioral Pharmacology Research Unit (BPRU) for human clinical and laboratory research.  She has […]

Read More »

Felipe Sarmiento Salazar, PhD

Flowering modulation in Cannabis sp. by night
interruption

June 19, 2024 11:00AM MT

Dr. Felipe Sarmiento Salazar is a biologist graduated from the Universidad de los Andes, doctor in Biology from the University of Freiburg and professor at the Department of Biology of the National University of Colombia since 2016. Professor Sarmiento has extensive experience in […]

Read More »

Institute of Cannabis Research

The Institute of Cannabis Research is the state of Colorado’s official cannabis research institute and is here to provide our citizenry with unbiased and objective scientific facts about cannabis biology, chemistry, health effects, economic impacts, and more.

 

Quick LInks

Follow Us On

Facebook Youtube Linkedin